Viewing Study NCT07190261


Ignite Creation Date: 2025-12-24 @ 12:32 PM
Ignite Modification Date: 2026-02-22 @ 10:36 PM
Study NCT ID: NCT07190261
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-24
First Post: 2025-09-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Sponsor: Bing Han
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module